Updates on Cell Therapy Symposium

---

LIVE

Friday, January 15, 2027, 8:00 AM - 5:00 PM, UT MD Anderson - Main Building, Hickey Auditorium (R11.1400), Houston, TX


AMA PRA Category 1 Credits™ (7.00 hours), AAPA Category 1 CME (7.00 hours), ANCC - Nursing Contact Hour(s) (7.00 hours), Non-Physician Attendance (7.00 hours)

The symposium will feature a keynote address by Michel Sadelain, MD, PhD, Director of the Center for Cell Engineering and Director of the Cellular Therapeutics Center at Columbia University Irving Medical Center, alongside presentations from internationally recognized experts in immunology, cancer biology, translational research, and cellular engineering. The program will explore emerging frontiers in cell therapy across cellular fitness and persistence, glioblastoma, off-the-shelf and iPSC-derived cell therapies, AI-driven single-cell and spatial technologies, autoimmunity, and the evolving regulatory landscape. Through these sessions, the symposium will examine innovative strategies for advancing cellular therapies from discovery and engineering to clinical application. Through engaging presentations, expert discussions, and opportunities for collaboration, the symposium will provide a forum for the exchange of ideas and the translation of groundbreaking discoveries from the laboratory to the clinic. Attendees will gain insight into emerging therapeutic strategies, clinical advances, and the challenges and opportunities shaping the future of cell therapy.

1. Evaluate the latest advances in NK-cell therapy, immune engineering, and other emerging cellular platforms.
2. Assess the significance of emerging clinical data and novel discoveries discussed by leading experts in the field.
3. Examine challenges in cell therapy, including treatment resistance, safety, manufacturing, and strategies to improve therapeutic efficacy.
4. Examine emerging approaches that have the potential to expand access to and applicability of cellular therapies.
5. Apply translational science principles to connect emerging research findings with clinical development and patient management considerations.
6. Apply collaborative approaches to promote knowledge exchange and support advances in cellular therapy development and implementation.

Advanced registration is encouraged. Virtual Registration will close on January 13, 2027, before noon. 

Virtual Attendees can access the virtual attendee link in the View Content tab above. The link will also be emailed no later than 1 day prior to the event. If you need to change your registration from In-Person to Virtual, please email: [email protected]

 

Registration is free for the Updates on Cell Therapy Symposium taking place on January 15, 2027.  

 

The Symposium will be held at MD Anderson Center, Main Building Floor 11, Hickey Auditorium, Room R11.1400, 1515 Holcombe Blvd. Houston, TX 77030, Houston, TX 77030, from 8 a.m. – 5 p.m. In-Person Registration is limited to 225 attendees.

 

REGISTRATION CATEGORIES

 

In-Person Attendee	Free
Virtual Attendee	Free

Cancellation Policy

The Department of Continuing Professional Education (CPE), reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary. Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form. In case of activity cancellation, the liability of the CPE is limited to the registration fee. CPE will refund the full registration fee.

CPE reserves the right to limit the number of participants in an activity and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available.

For additional information, contact CPE at 713-792-2223 or toll free at 866-849-5866 or via e-mail: [email protected].

 

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation:

The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University of Texas MD Anderson Cancer Center has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 7.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

The University of Texas MD Anderson Cancer Center designates this live activity will award 7.75 Nursing Contact Hour(s).

View the accessibility policy for The University of Texas MD Anderson Cancer Center.

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, January 15, 2027